Cassava Sciences Latest Filings
Event
03/11/2025
Form 8-K - Current report
Item 5.02: Changes in Executive Management
Interim
03/03/2025
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
Event
03/03/2025
Form 8-K - Current report
Report Period: Q4' FY2024
Financial Results:
: revenue $0.00, estimate $0.00, prior $0.00;
: EPS $-0.57, concensus $-0.68, prior $-0.50
Event
02/27/2025
Form 8-K - Current report
Item 1.01: Entry into Definitive Agreement
Item 7.01: Regulation FD Disclosure
Event
01/07/2025
Form 8-K - Current report
Item 2.02: Results of Operations
Item 2.05: Costs of Exits or Disposals
Item 8.01: Other Events
Ownership
12/03/2024
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
12/03/2024
Form 4 - Statement of changes in beneficial ownership of securities
Ownership
12/02/2024
Form 144 - Report of proposed sale of securities
Ownership
11/29/2024
Form 144 - Report of proposed sale of securities
11/26/2024
Form SCHEDULE 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
Show More Filings
